Updates on Cell Therapy Symposium

---

LIVE

Tuesday, November 5, 2024, 9:00 AM - 4:00 PM

The ACT Platform’s “Updates on Cell Therapy Symposium”, hosted by Dr. Katy Rezvani, MD, PhD, Vice President and Head of the Cell Therapy Institute will bring together leading experts in the field of cell therapy at MD Anderson Cancer Center. Attendees can look forward to insightful presentations and discussions led by top scientists specializing in immunology, translational research, and innovative cell therapies. The symposium aims to foster collaboration and showcase the latest advancements in cell therapy, providing a valuable platform for exploring novel strategies in cancer treatment and improving patient outcomes.

 

Keynote speaker:

Dr. Nick Huntington

Head of the Cancer Immunotherapy Laboratory at the Biomedicine Discovery Institute

Monash University, Australia 

 

Advanced registration is encouraged.  Registration will close on November 4, 2024.

 

Registration is Free to attend this Updates on Cell Therapy Symposium to be held November 5, 2024.  

 

The Symposium will be held at Sheikh Zayed Building, Z2 Ballroom - Z2.4040, Rooms 1-6, 6565 MD Anderson Blvd. Houston, TX 77030, Houston, TX 77030, from 9 a.m. – 4 p.m. Registration is limited to 150 in-person attendees.

 

You may also attend virtually. The virtual event link is available in the "View Content" tab after you register for the event.

 

REGISTRATION CATEGORIES

 

In-Person Attendee	Fee Exempt
Virtual Attendee	Fee Exempt

 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.